German stem cell ethics commission in place:
This article was originally published in Clinica
The German central ethics commission for stem cell research met last week for the first time at the Robert Koch Institute (RKI) for hygiene and infectious diseases. The commission has the responsibility of evaluating proposals for the import and use of human embryonic stem cells for research purposes. One proposal has already been submitted according to the RKI. Philosophy professor Ludwig Siep was elected chairman, with medical professor Marion Kiechle and biology professor Henning Beier selected as deputies.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.